- Home
- HBNC vs TLRY Comparison
HBNC vs TLRY Comparison
Compare HBNC & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBNC | TLRY |
|---|---|---|
| Founded | 1873 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.0M | 688.9M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HBNC | TLRY |
|---|---|---|
| Price | $17.60 | $5.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $21.00 | ★ $72.33 |
| AVG Volume (30 Days) | 248.9K | ★ 7.0M |
| Earning Date | 04-22-2026 | 04-01-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | $5.52 | $19.98 |
| P/E Ratio | $35.02 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.38 | $0.36 |
| 52 Week High | $19.07 | $15.70 |
Technical Indicators
Market Signals| Indicator | HBNC | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 32.23 |
| Support Level | $17.07 | $1.12 |
| Resistance Level | $18.73 | $7.01 |
| Average True Range (ATR) | 0.47 | 0.25 |
| MACD | -0.11 | -0.07 |
| Stochastic Oscillator | 23.84 | 4.99 |
Price Performance
Historical ComparisonAbout HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.